Shubh Goel: I’m starting a new position as VP, Global Franchise Head, BiSpecifics at AstraZeneca
Shubh Goel shared a post on LinkedIn:
”I’m happy to share that I’m starting a new position as VP, Global Franchise Head, BiSpecifics at AstraZeneca!”
Source: Shubh Goel/LinkedIn
Shubh Goel is the Vice President, Global Franchise Head for BiSpecifics at AstraZeneca. She also served as the VP, Head of Immuno-Oncology and GI Tumors Franchise for US Oncology at AstraZeneca, where she leaded sales, marketing, and cross-functional team efforts across the Immuno-Oncology portfolio and GI sales teams. She holds a Bachelor of Science degree in Biochemistry from the University of Bath. Shubh previously served as the Chief Commercial Officer at Fennec Pharmaceuticals, a late-stage biotechnology company focused on improving the lives of children with cancer. Her career includes various leadership roles in commercial strategy and marketing at companies like Odonate Therapeutics, Celgene, Bayer AG, Aveo Oncology, Ariad Pharmaceuticals, and Millennium Pharmaceuticals. With over 20 years of experience, she specializes in developing and executing commercial strategies for successful oncology product launches in the U.S. and global markets.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023